RxDoctor Payments Data

Allison Dallas

Family · Abilene, TXNPI 1144005620

Payments from drug & device makers

$707in general payments, 2019–2025

Across 31 payments — averaging $22.81 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$191
  • Novo Nordisk$118
  • Exact Sciences$108
  • Amgen$65
  • Inspire Medical Systems, Inc.$32
  • Abiomed$31
  • plus $161 from 8 others

What the payments were for

  • Food & beverage$707100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$707 in reported general payments places this provider in the 60th percentile of 15,456 family providers in Texas.

See all family providers in Texas

Medicare billing

Part B allowed, 2024
$56,966
Medicare patients
179
Services billed
1,187

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
JardianceEmpagliflozin15$19,716
OzempicSemaglutide15$13,097
EliquisApixaban18$10,583
Trelegy ElliptaFluticasone/Umeclidin/Vilanter11$9,761
Albuterol Sulfate HfaAlbuterol Sulfate41$718
Doxycycline Hyclate85$698
Rosuvastatin Calcium44$557
Pregabalin50$500
Atorvastatin Calcium27$414
Duloxetine Hcl25$371
Potassium Chloride33$365
Trazodone Hcl46$365
Levothyroxine Sodium30$342
Lisinopril34$339
Clobetasol Propionate13$319

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Boehringer IngelheimJardiance$31$19,71615 claims
Novo NordiskOzempic$118$13,09715 claims
PfizerEliquis$16$10,58318 claims
GSKTrelegy Ellipta$16$9,76111 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 60th percentile of 15,456 family providers in Texas.

Other family in Abilene

See the full list for Texas

Where these figures come from

Is this you, or does something look wrong? →